Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, with therapeutic and preventive approaches advancing in parallel.

In a recent study posted to Research Square* preprint server, researchers assessed the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV envelope (E) proteins on ...

HIV-2 and HIV-1 are both types of human immunodeficiency virus (HIV). They are both transmitted the same way, but HIV-2 does not spread as easily and progresses to AIDS more slowly. Those with HIV-2 ...

Studies have shown that both SARS-CoV-2 and HIV-1 are RNA viruses and have higher mutation rates than DNA viruses. Although both the viruses have been characterized as highly virulent, the manner of ...